Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D07WHN
|
|||
| Former ID |
DIB016924
|
|||
| Drug Name |
FASORACETAM
|
|||
| Synonyms |
LAM-105; NS-105; Fasoracetam; (R)-1-[(5-Oxo-2-pyrrolidinyl)carbonyl]piperidine; (R)-5-(Piperidin-1-ylcarbonyl)pyrrolidin-2-one
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Cognitive impairment [ICD-11: 6D71; ICD-10: F06.7] | Phase 3 | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C10H16N2O2
|
|||
| Canonical SMILES |
C1CCN(CC1)C(=O)C2CCC(=O)N2
|
|||
| InChI |
1S/C10H16N2O2/c13-9-5-4-8(11-9)10(14)12-6-2-1-3-7-12/h8H,1-7H2,(H,11,13)/t8-/m1/s1
|
|||
| InChIKey |
GOWRRBABHQUJMX-MRVPVSSYSA-N
|
|||
| CAS Number |
CAS 110958-19-5
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:31592
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Glutamate receptor AMPA (GRIA) | Target Info | Modulator | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800003134) | |||
| REF 2 | Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015 | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.